{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:29:19Z","timestamp":1789540159578,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1038\/sj.leu.2402320","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:45:09Z","timestamp":1031251509000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies"],"prefix":"10.1038","volume":"16","author":[{"given":"D","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MR","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Barendswaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MW","family":"Brechbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,1,24]]},"reference":[{"key":"BF2402320_CR1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.7326\/0003-4819-132-11-200006060-00012","volume":"132","author":"OW Press","year":"2000","unstructured":"Press OW . Emerging immunotherapies for non-Hodgkin lymphoma: the tortoise approaches the finish line Ann Intern Med 2000 132: 916\u2013918","journal-title":"Ann Intern Med"},{"key":"BF2402320_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0952-7915(99)00017-5","volume":"11","author":"SJ Denardo","year":"1999","unstructured":"Denardo SJ, Kroger LA, Denardo GL . A new era for radiolabeled antibodies in cancer Curr Opin Immunol, 1999 11: 563\u2013569","journal-title":"Curr Opin Immunol,"},{"key":"BF2402320_CR3","first-page":"2","volume":"17","author":"MS Kaminski","year":"1998","unstructured":"Kaminski MS, Gribbin T, Estes J, Ross CW, Regan D, Zasadny K, Tamminen J, Kison P, Tuck M, Fisher S . I-131 anti-B1 antibody for previously untreated follicular lymphoma (FL): clinical and molecular remissions Proc Am Soc Clin Oncol 1998 17: 2","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF2402320_CR4","first-page":"457","volume":"2","author":"SJ Knox","year":"1996","unstructured":"Knox SJ, Goris ML, Trisler K, Negrin R, Davis T, Liles TM, Grillo-Lopez A, Chinn P, Varns C, Ning SC, Fowler S, Deb N, Becker M, Marquez C, Levy R . Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma Clin Cancer Res 1996 2: 457\u2013470","journal-title":"Clin Cancer Res"},{"key":"BF2402320_CR5","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1200\/JCO.1998.16.10.3246","volume":"16","author":"SJ DeNardo","year":"1998","unstructured":"DeNardo SJ, Denardo GI, Goldstein DS, Kroger LA, Lamborn KR, Levey NB, McGahan JP, Salako Q, Shen S, Lewis JP . Maximum tolerated dose, toxicity, and efficacy of I-131-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma J Clin Oncol 1998 16: 3246\u20133256","journal-title":"J Clin Oncol"},{"key":"BF2402320_CR6","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood.V87.9.3640.bloodjournal8793640","volume":"87","author":"CA White","year":"1996","unstructured":"White CA, Halpern SE, Parker BA, Miller RA, Hupf HB, Shawler DL, Collins HA, Royston I . Radioimmunotherapy of relapsed B-cell lymphoma with yttrium-90 anti-idiotype monoclonal antibodies Blood 1996 87: 3640\u20133649","journal-title":"Blood"},{"key":"BF2402320_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","volume":"329","author":"OW Press","year":"1993","unstructured":"Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher DR, Porter B, Matthews DC, Fisher LD, Berstein ID . Radiolabeled antibody therapy of B cell lymphoma with autologous bone marrow support N Engl J Med 1993 329: 1219\u20131224","journal-title":"N Engl J Med"},{"key":"BF2402320_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJM199308123290703","volume":"329","author":"MS Kaminski","year":"1993","unstructured":"Kaminski MS, Zasadny KR, Francis IR, Milik AW, Ross CW, Moon SD, Crawford SM, Burgess JM, Petry NA, Butchko GM, Glenn SD, Wahl RL . Radioimmunotherapy of B-cell lymphoma with I-131 anti-B1 (anti-CD20) antibody N Engl J Med 1993 329: 459\u2013465","journal-title":"N Engl J Med"},{"key":"BF2402320_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10428190009060322","volume":"38","author":"JM Vose","year":"2000","unstructured":"Vose JM . Colcher D. Gobar L. Bierman PJ. Augustine S. Tempero M. Leichner P. Lynch JC. Goldenberg D. Armitage JO. Phase I\/II trial of multiple dose Iodine-131-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma Leuk Lymphoma 2000 38: 91\u2013101","journal-title":"Leuk Lymphoma"},{"key":"BF2402320_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/10428199509059636","volume":"18","author":"RH Scheurmann","year":"1995","unstructured":"Scheurmann RH, Racila E . CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy Leuk Lymphoma 1995 18: 385\u2013397","journal-title":"Leuk Lymphoma"},{"key":"BF2402320_CR11","first-page":"265","volume":"43","author":"DA Scheinberg","year":"1983","unstructured":"Scheinberg DA, Strand M . Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice Cancer Res 1983 43: 265\u2013272","journal-title":"Cancer Res"},{"key":"BF2402320_CR12","first-page":"2123","volume":"56","author":"OW Press","year":"1996","unstructured":"Press OW, Shan D, Howell-Clark J, Eary J, Appelbaum FR, Matthews D, King DJ, Haines AMR, Hamann P, Hinman L, Shochat D, Bernstein ID . Comparative metabolism and retention of Iodine-125, Yttrium-90, and Indium-111 radioimmunoconjugates by cancer cells Cancer Res 1996 56: 2123\u20132129","journal-title":"Cancer Res"},{"key":"BF2402320_CR13","first-page":"3292s","volume":"5","author":"ME Juweid","year":"1999","unstructured":"Juweid ME, Stadtmauer E, Hajjar G, Sharkey RM, Suleiman S, Luger S, Swayne LC, Alavi A, Goldenberg DM . Pharmacokinetics, dosimetry, and initial therapeutic results with I-131 and In-111\/Y-90 labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma Clin Cancer Res 1999 5: 3292s\u20133303s","journal-title":"Clin Cancer Res"},{"key":"BF2402320_CR14","first-page":"2627","volume":"55","author":"E Hooijberg","year":"1995","unstructured":"Hooijberg E, Sein JJ, van den Berk PCM, Hart AAM, van der Valk MA, Kast WM, Melief CJM, Kekman A . Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2 Cancer Res 1995 55: 2627\u20132634","journal-title":"Cancer Res"},{"key":"BF2402320_CR15","first-page":"611","volume":"5","author":"TA Davis","year":"1999","unstructured":"Davis TA, Czerwinski DK, Levy R . Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression Clin Cancer Res 1999 5: 611\u2013615","journal-title":"Clin Cancer Res"},{"key":"BF2402320_CR16","first-page":"6476","volume":"52","author":"DJ Buchsbaum","year":"1992","unstructured":"Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS . Therapy with unlabeled and I-131 labeled Pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts Cancer Res 1992 52: 6476\u20136481","journal-title":"Cancer Res"},{"key":"BF2402320_CR17","first-page":"631","volume":"6","author":"BR Wei","year":"2000","unstructured":"Wei BR, Ghetie MA, Vitetta ES . The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B-cell lymphoma in immunodeficient mice Clin Cancer Res 2000 6: 631\u2013642","journal-title":"Clin Cancer Res"},{"key":"BF2402320_CR18","first-page":"6761","volume":"52","author":"PC Caron","year":"1992","unstructured":"Caron PC, Sung Co M, Bull MK, Avdalovic NM, Queen C, Scheinberg DA . Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies Cancer Res 1992 52: 6761\u20136767","journal-title":"Cancer Res"},{"key":"BF2402320_CR19","doi-asserted-by":"crossref","unstructured":"Brechbiel MW, Gansow OA . Synthesis of C-functionalised transcyclohexyldiethylenetriaminepentaacetic acids for labeling of monoclonal antibodies with the bismuth-212 a-particle emitter J Chem Soc Perkin Trans I 1992 1173\u20131178","DOI":"10.1039\/P19920001173"},{"key":"BF2402320_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0969-8051(94)00126-5","volume":"22","author":"TK Nikula","year":"1995","unstructured":"Nikula TK, Curcio MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA . A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies Nucl Med Bio 1995 22: 387\u2013390","journal-title":"Nucl Med Bio"},{"key":"BF2402320_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/bc00016a014","volume":"3","author":"CG Pippin","year":"1992","unstructured":"Pippin CG, Parker TA, McMurry TJ, Brechbiel MW . Spectrophotometric method for the determination of a bifuctional DTPA ligand in DTPA-monoclonal antibody conjugates Bioconjugate Chem 1992 3: 342\u2013345","journal-title":"Bioconjugate Chem"},{"key":"BF2402320_CR22","first-page":"1230","volume":"39","author":"VL Gates","year":"1998","unstructured":"Gates VL, Carey JE, Siegel JA, Kaminski MS ., Wahl RL. Nonmyeloabaltive Iodine-131 anti-B1 radioimmunotherapy as outpatient therapy J Nucl Med 1998 39: 1230\u20131236","journal-title":"J Nucl Med"},{"key":"BF2402320_CR23","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1200\/JCO.1998.16.10.3270","volume":"16","author":"SY Liu","year":"1998","unstructured":"Liu SY, Eary JF, Petersdorf SH, Matin PJ, Maloney DG, Appelbaum FR, Matthews DC, Bush SA, Durack LD, Fisher DR, Gooley TA, Bernstein ID, Press OW . Follow-up of relapsed B-cell lymphoma patients treated with Iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue J Clin Oncol 1998 16: 3270\u20133278","journal-title":"J Clin Oncol"},{"key":"BF2402320_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s002620050285","volume":"42","author":"SF Vervoordeldonk","year":"1996","unstructured":"Vervoordeldonk SF, Heikens J, Goedemans WT, Merle PA, non dem Borne AE, van Royen EA, Slaper-Cortenbach IC, van Oers RH . 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma Cancer Immunol Immunother 1996 42: 291\u2013296","journal-title":"Cancer Immunol Immunother"},{"key":"BF2402320_CR25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/blood.V83.6.1632.1632","volume":"83","author":"SF Vervoordeldonk","year":"1994","unstructured":"Vervoordeldonk SF, Merle PA, van Leeuwen EF, van der Schoot CE, von dem Borne AE, Slaper-Cortenbach IC . Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody Blood 1994 83: 1632\u20131639","journal-title":"Blood"},{"key":"BF2402320_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s002620050247","volume":"42","author":"SF Vervoordeldonk","year":"1996","unstructured":"Vervoordeldonk SF, Balkenende AY, van den Berg H, von dem Borne AE, van der Schoot CE, van Leeuwen EF, Slaper-Cortenbach IC . Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FC gamma receptor II mediated mechanism and by drugs Cancer Immunol Immunother 1996 42: 24\u201330","journal-title":"Cancer Immunol Immunother"},{"key":"BF2402320_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s002620050371","volume":"44","author":"RM Sharky","year":"1997","unstructured":"Sharky RM, Behr TM, Mattes MJ, Stein R, Griffiths GL, Shih LB, Hansen HJ, Blumenthal RD, Dunn RM, Juweid ME, Goldenberg DM . Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22 Cancer Immunol Immunother 1997 44: 179\u2013188","journal-title":"Cancer Immunol Immunother"},{"key":"BF2402320_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s002770050576","volume":"79","author":"TA Johnson","year":"2000","unstructured":"Johnson TA, Press OW . Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience Ann Hematol 2000 79: 175\u2013182","journal-title":"Ann Hematol"},{"key":"BF2402320_CR29","first-page":"268","volume":"40","author":"JA Carrasquillo","year":"1999","unstructured":"Carrasquillo JA, White JD, Paik CH, Raubitschek A, Le N, Rotman M, Brechbiel MW, Gansow OA, Top LE, Perentesis P, Reynolds JC, Nelson DL, Waldmann TA . Similarities and differences in In-111 and Y-90-labeled 1B4M-DTPA anti-Tac monoclonal antibody distribution J Nucl Med 1999 40: 268\u2013276","journal-title":"J Nucl Med"},{"key":"BF2402320_CR30","first-page":"2599","volume":"4","author":"PS Multani","year":"1998","unstructured":"Multani PS, O'Day S, Nadler LE, Grossbard ML . Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma Clin Cancer Res 1998 4: 2599\u20132604","journal-title":"Clin Cancer Res"},{"key":"BF2402320_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.leu.2401779","volume":"14","author":"L Herrera","year":"2000","unstructured":"Herrera L, Farah RA, Pellegrini VA, Aquino DB, Sandler ES, Buchanan GR, Vitetta ES . Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro Leukemia 2000 14: 853\u2013858","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:54:38Z","timestamp":1648763678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["BF2402320"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402320","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]},"assertion":[{"value":"21 February 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}